Health Boards
›
Psoriasis In The News
Efficacy & safety of IL-17 & IL-23 inhibitors in elderly psoriasis patients
|
Efficacy & safety of IL-17 & IL-23 inhibitors in elderly psoriasis patients
|
Sat-31-05-2025, 11:35 AM
Sorry Fred ,yes it's IL12 but what I should have said is Stelara does not directly target IL-17, but it does affect the IL-17 pathway. Stelara is a human monoclonal antibody that binds to the shared p40 subunit of IL-12 and IL-23. By blocking these cytokines, it indirectly influences the IL-17 pathway.
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
IL-23 and IL-17 inhibitors versus other biologics for psoriasis | Fred | 0 | 473 |
Fri-30-05-2025, 15:40 PM Last Post: Fred |
|
|
Cardiovascular safety of systemic psoriasis treatments cohort study | Fred | 4 | 1,107 |
Thu-01-05-2025, 12:53 PM Last Post: Fred |
|
|
Tremfya Japanese safety and efficacy study | Fred | 0 | 537 |
Sat-29-03-2025, 12:33 PM Last Post: Fred |
|
|
IL 17 & 23 with elderly psoriasis patients | Fred | 0 | 1,268 |
Thu-13-06-2024, 13:56 PM Last Post: Fred |
|
|
Atopic like dermatitis induced by IL-17A inhibitors for psoriasis | Fred | 1 | 2,441 |
Wed-02-08-2023, 20:20 PM Last Post: Caroline |
